Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes
<p><strong>OBJECTIVE</strong> Maturity-onset diabetes of the young (MODY) due to variants in HNF1A is the commonest type of monogenic diabetes. Frequent misdiagnosis results in missed opportunity to use sulfonylureas as first-line treatment. A nongenetic biomarker could improve sel...
Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , |
---|---|
Materyal Türü: | Journal article |
Baskı/Yayın Bilgisi: |
American Diabetes Association
2018
|